BIOCON.NS Overview

Company Profile

Related stocks

ANTHEM.NS • India

ANTHEM BIOSCIENCES LTD

862.3 INR

5B USD 1Y +13.1%

0126Z0.KS • South Korea

SAMSUNG EPIS HOLDINGS

340,500 KRW

6.32B USD

688336.SS • China

SUNSHINE GUOJIAN PHARMACEUTICAL

38.1 CNY

5.11B USD 1Y +4.2%

ONESOURCE.NS • India

ONESOURCE SPECL PHARMA L

1,461.3 INR

1.73B USD 1Y -22.7%

002252.SZ • China

SHANGHAI RAAS

5.06 CNY

4.99B USD 1Y -25.4%

688428.SS • China

INNOCARE PHARMA LTD

28.12 CNY

7.44B USD 1Y +5.2%

9995.HK • China

REMEGEN

70.4 HKD

5.34B USD 1Y -33.7%

1530.HK • China

3SBIO

15.07 HKD

4.76B USD 1Y -47.3%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

Region

Sector

Industry

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

31.4% p.a.

Max Drawdown (5Y)

-51.2%

Sharpe Ratio (5Y)

-0.10

Beta Factor

0.32

Size Class

Mega Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

🔴 High valuation risk: Avg P/E of 103.4 (Elevated multiple compression risk)

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (31.4% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -58.9% in the extended horizon.